Effects of cyclin-dependent kinase inhibitors on transcription and ocular circadian rhythm of Aplysia

Journal of Neurochemistry

Volumn 72, Issue 2, 1999, Pages 605-613

  Sankrithi, Nagarajan ^a,b   Eskin, Arnold ^a  

^a University of Houston   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Aplysia; Circadian; Cyclin dependent kinases; Mollusk; Olomoucine; Transcription

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; BUTYROLACTONE 1; CYCLIN DEPENDENT KINASE INHIBITOR; DIMETHYL SULFOXIDE; ISOOLOMOUCINE; LACTONE DERIVATIVE; LEUCINE; MESSENGER RNA; OLOMOUCINE; ROSCOVITINE; TRITIUM; UNCLASSIFIED DRUG; URIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APLYSIA; ARTICLE; CIRCADIAN RHYTHM; CONCENTRATION RESPONSE; CONTROLLED STUDY; EYE; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; RNA SYNTHESIS;

4-BUTYROLACTONE; ACTION POTENTIALS; ANIMALS; APLYSIA; CIRCADIAN RHYTHM; CYCLIN-DEPENDENT KINASES; ELECTROPHYSIOLOGY; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; KINETIN; MACROMOLECULAR SUBSTANCES; NEURAL CONDUCTION; OCULAR PHYSIOLOGY; PURINES; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0032955427     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0720605.x     Document Type: Article

References (50)

1. Abraham R. T., Acquarone M., Anderson A., Asensi A., Belle R., Berger F., Bergounioux C., Brunn G., Buquet-Fagot C., Fagot D., Glab N., Goudeau H., Goudeau M., Guerrier P., Houghton P., Hendriks H., Kloareg B., Lippai M., Marie D., Maro B., Meijer L., Mester J., Mulner-Lorillon O., Poulet S. A., Scheirenberg E., Schutte B., Vaulot D., and Verlhac M. H. (1995) Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases. J. Cell Biol. 83, 105-120.
2. Alberini C. M., Ghirardi M., Metz R., and Kandel E. R. (1994) C/EBP is an immediate-early gene required for the consolidation of long-term facilitation in Aplysia. Cell 76, 1099-1114.
3. Aronson B. D., Johnson K. A., Loros J. J., and Dunlap J. C. (1994) Negative feedback defining a circadian clock: autoregulation of the clock gene Frequency. Science 263, 1578-1584.
4. Block G. D. and Wallace S. (1982) Localization of a circadian pacemaker in the eye of a mollusk, Bulla. Science 217, 155-157.
5. Comolli J., Taylor W., and Hastings J. W. (1994) An inhibitor of protein phosphorylation stops the circadian oscillator and blocks light-induced phase shifting in Gonyaulax polyedra. J. Biol. Rhythms 9, 13-26.
6. Dubois M. F., Nguyen V. T., Bellier S., and Bensaude O. (1994) Inhibitors of transcription such as 5,6-dichloro-1-β-d-ribofuranosylbenzimidazole and isoquinoline sulfonamide derivatives (H-8 and H-7*) promote dephosphorylation of the carboxyl-terminal domain of RNA polymerase II largest subunit. J. Biol. Chem. 269, 13331-13336.
7. Edery I., Zwiebel L. J., Dembinska M. E., and Rosbash M. (1994) Temporal phosphorylation of the Drosophila period protein. Proc. Natl. Acad. Sci. USA 91, 2260-2264.
8. Eskin A. and Corrent G. (1977) Effects of divalent cations and metabolic poisons on the circadian rhythm from the Aplysia eye. J. Comp. Physiol. 117, 1-21.
9. Eskin A., Corrent G., Lin C. Y., and McAdoo D. J. (1982) Mechanism of shifting the phase of a circadian rhythm by serotonin: involvement of cAMP. Proc. Natl. Acad. Sci. USA 79, 660-664.
10. Eskin A., Takahashi J. S., Zatz M., and Block G. D. (1984) Cyclic guanosine 3':5′-monophosphate mimics the effects of light on a circadian pacemaker in the eye of Aplysia. J. Neurosci. 4, 2466-2471.
11. Garceau N. Y., Liu Y., Loros J. J., and Dunlap J. C. (1997) Alternative initiation of translation and time-specific phosphorylation yield multiple forms of the essential clock protein Frequency. Cell 89, 1-20.
12. L. Science 270, 811-815.
13. Hardin P. E., Hall J. C., and Rosbash M. (1990) Feedback of the Drosophila period gene product on circadian cyclin of its messenger RNA levels. Nature 343, 536-540.
14. Hunter-Ensor M., Ousley A., and Sehgal A. (1996) Regulation of the Drosophila protein timeless suggests a mechanism for resetting the circadian clock by light. Cell 84, 677-685.
15. Jacklet J. W. (1969) Circadian rhythm of optic nerve impulses recorded in darkness from isolated eye of Aplysia. Science 164, 562-563.
16. Kaffman A., Herskowitz I., Tjian R., and O'Shea E. K. (1994) Phosphorylation of the transcription factor PHO4 by a cyclin-CDK complex, PHO80-PHO85. Science 263, 1153-1156.
17. Kennedy T. E., Kuhl D., Barzilai A., Sweatt J. D., and Kandel E. R. (1992) Long-term sensitization training in Aplysia leads to an increase in calreticulin, a major presynaptic calcium-binding protein. Neuron 9, 1013-1024.
18. Khalsa S. B. S., Whitmore D., Bogart B., and Block G. D. (1996) Evidence for a central role of transcription in the timing mechanism of a circadian clock. Am. J. Physiol. 271, C1646-C1651.
19. Kitagawa M., Okabe T., Ogino H., Matsumoto H., Suzuki-Takahashi I., Kokubo T., Higashi H., Saitoh S., Taya Y., Yasuda H., Ohba Y., Nishimura S., Tanaka N., and Okuyama A. (1993) Butyrolactone I, a selective inhibitor of CDK2 and Cdc2 kinase. Oncogene 8, 2425-2432.
20. Koumenis C., Tran Q., and Eskin A. (1996) The use of a reversible transcription inhibitor, DRB, to investigate the involvement of specific proteins in the ocular circadian system of Aplysia. J. Biol. Rhythms 11, 45-56.
21. Krucher N. A. and Roberts M. H. (1994) Identification of CDK-like and cyclin-like molecules in the eye of Bulla gouldiana. J. Neurobiol. 25, 1200-1206.
22. Krucher N. A., Meijer L., and Roberts M. H. (1997) The cyclin-dependent kinase (CDK) inhibitors, olomoucine and roscovitine, alter the expression of a molluskan circadian pacemaker. Cell. Mol. Neurobiol. 17, 495-507.
23. Liu Q. R., Hattar S., Endo S., MacPhee K., Zhang H., Cleary L. J., Byrne J. H., and Eskin A. (1997) A developmental gene (Tolloid/ BMP-1) is regulated in Aplysia neurons by treatments that induce long-term sensitization. J. Neurosci. 17, 755-764.
24. Mathur A., Golombek D. A., and Ralph M. R. (1996) cGMP-dependent protein kinase inhibitors block light induced phase advances of circadian rhythms in vivo. Am. J. Physiol. 270, R1031-R1036.
25. Meijer L., Borgne A., Mulner O., Chong J. P., Blow J. J., Inagaki N., Inagaki M., Delcros J. G., and Moulinoux J. P. (1997) Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243, 527-536.
26. Nigg E. A. (1996) Cyclin-dependent kinase 7: at the cross-roads of transcription, DNA repair and cell cycle control? Curr. Opin. Cell Biol. 8, 312-317.
27. Ohi K. and Takahashi J. S. (1991) Effects of the transcriptional inhibitor, 5,6-dichloro-1-β-d-ribobenzimidazole (DRB), on the circadian melatonin rhythm of cultured chick pineal cells. Soc. Neurosci. Abstr. 17, 675.
28. Park D. S., Morris E. J., Greene L. A., and Geller H. M. (1997) G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis. J. Neurosci. 17, 1256-1270.
29. Pines J. (1996) Cyclin: from sea urchins to helas: making the human cell cycle. Biochem. Soc. Trans. 24, 15-33.
30. Price J. L., Blau J., Rothenfluh A., Abodeely M., Kloss B., and Young M. W. (1998) double-time is a novel Drosophila clock gene that regulates PERIOD protein accumulation. Cell 94, 83-95.
31. + channel opening. Brain Res. 644, 67-73.
32. Raju U., Koumenis C., Nunez-Regueiro M., and Eskin A. (1991) Alteration of the phase and period of a circadian oscillator by a reversible transcription inhibitor. Science 253, 673-675.
33. Roberts M. H., Bedian V., and Chen Y. (1989) Kinase inhibition lengthens the period of the circadian pacemaker in the eye of Bulla gouldiana. Brain Res. 504, 211-215.
34. Roberts M. H., Towles J. A., and Leader N. K. (1992) Tyrosine kinase regulation of a molluscan circadian clock. Brain Res. 592, 170-174.
35. Roy R., Adamczewski J. P., Seroz T., Vermeulen W., Tassan J. P., Schaeffer L., Nigg E. A., Hoejimakers J. H. J., and Egly J. M. (1994) The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell 79, 1093-1101.
36. Sankrithi N., Tran Q., and Eskin A. (1996) Olomoucine, a cyclin-dependent kinase inhibitor, phase shifts the Aplysia eye rhythm possibly via inhibition of transcription. Soc. Neurosci. Abstr. 22, 1398.
37. Sehgal A., Rothenfluh-Hilfiker A., Hunter-Ensor M., Chen Y., Myers M., and Young M. W. (1995) Rhythmic expression of Timeless: a basis for promoting circadian cycles in Period gene autoregulation. Science 270, 808-810.
38. Serizawa H., Conway R. C., and Conway J. W. (1993) Phosphorylation of C-terminal domain of RNA polymerase II is not required in basal transcription. Nature 363, 371-374.
39. Serizawa H., Makela T. P., Conaway J. W., Conaway R. C., Weinberg R. A., and Young R. A. (1995) Association of CDK-activating kinase subunits with TFIIH. Nature 374, 280-282.
40. Sheikhattar R., Mermelstein F., Fisher R., Drapkin R., Dynlacht B., Wessling H. C., Morgan D. O., and Reinberg D. (1995) CDK-activating kinase complex is a component of transcription factor TFIIH. Nature 374, 283-287.
41. Sloan M. and Eskin A. (1995) Effects of phase shifting treatments on the mRNA levels of putative oscillator proteins, BiP and porin in the Aplysia. Soc. Neurosci. Abstr. 21, 1675.
42. Tamm I. and Sehgal P. B. (1978) Halobenzimidazole ribosides and RNA synthesis of cells and viruses. Adv. Virus Res. 22, 187-258.
43. Tanaka T., Iqbal K., Trenkner E., Takeda M., and Grundke-Iqbal I. (1996) Butyrolactone I, a cyclin-dependent kinase inhibitor, induces dephosphorylation of tau and differentiates SY5Y cells. Soc. Neurosci. Abstr. 22, 974.
44. Toh-e A., Tanaka K., Uesono Y., and Wickner R. B. (1988) PHO85, a negative regulator of the PHO system, is a homolog of the protein kinase gene, CDC28, of Saccharomyces cerevisiae. Mol. Gen. Genet. 214, 162-164.
45. Tsai L. H., Takahashi T., Caviness V. S., and Harlow E. (1993) Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development 119, 1029-1040.
46. Vesely J., Havlicek L., Strnad M., Blow J. J., Donella-Deana A., Pinna L., Letham D. S., Kato J., Detivaud L., Leclerc S., and Meijer L. (1994) Inhibition of cyclin-dependent kinases by purine analogues. Eur. J. Biochem. 224, 771-786.
47. Vosshall L. B., Price J. L., Sehgal A., Saez L., and Young M. W. (1994) Block in nuclear localization of Period protein by a second clock mutation. Timeless. Science 263, 1606-1609.
48. Weber E. T., Cannon R. L., and Rea M. A. (1995) cGMP-dependent protein kinase inhibitor blocks light-induced phase advances of circadian rhythms in vivo. Neurosci. Lett. 197, 227-230.
49. Yeung S. J. and Eskin A. (1988) Responses of the circadian system in the Aplysia eye to inhibitors of protein synthesis. J. Biol. Rhtthms 3, 225-236.
50. Zandomeni R., Zandomeni M. C., Shugar D., and Weinmann R. (1986) Casein kinase type II is involved in the inhibition by 5,6-dichloro-1-β-d-ribofuranosylbenzimidazole of specific RNA polymerase II transcription. J. Biol. Chem. 261, 3414-3419.